251 related articles for article (PubMed ID: 35305696)
21. Serine 421 regulates mutant huntingtin toxicity and clearance in mice.
Kratter IH; Zahed H; Lau A; Tsvetkov AS; Daub AC; Weiberth KF; Gu X; Saudou F; Humbert S; Yang XW; Osmand A; Steffan JS; Masliah E; Finkbeiner S
J Clin Invest; 2016 Sep; 126(9):3585-97. PubMed ID: 27525439
[TBL] [Abstract][Full Text] [Related]
22. Herp Promotes Degradation of Mutant Huntingtin: Involvement of the Proteasome and Molecular Chaperones.
Luo H; Cao L; Liang X; Du A; Peng T; Li H
Mol Neurobiol; 2018 Oct; 55(10):7652-7668. PubMed ID: 29430620
[TBL] [Abstract][Full Text] [Related]
23. Pramipexole reduces soluble mutant huntingtin and protects striatal neurons through dopamine D3 receptors in a genetic model of Huntington's disease.
Luis-Ravelo D; Estévez-Silva H; Barroso-Chinea P; Afonso-Oramas D; Salas-Hernández J; Rodríguez-Núñez J; Acevedo-Arozena A; Marcellino D; González-Hernández T
Exp Neurol; 2018 Jan; 299(Pt A):137-147. PubMed ID: 29056363
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-27a reduces mutant hutingtin aggregation in an in vitro model of Huntington's disease.
Ban JJ; Chung JY; Lee M; Im W; Kim M
Biochem Biophys Res Commun; 2017 Jun; 488(2):316-321. PubMed ID: 28495533
[TBL] [Abstract][Full Text] [Related]
25. Neural stem cells derived from the developing forebrain of YAC128 mice exhibit pathological features of Huntington's disease.
Li E; Park HR; Hong CP; Kim Y; Choi J; Lee S; Park HJ; Lee B; Kim TA; Kim SJ; Kim HS; Song J
Cell Prolif; 2020 Oct; 53(10):e12893. PubMed ID: 32865873
[TBL] [Abstract][Full Text] [Related]
26. Huntingtin affinity for partners is not changed by polyglutamine length: aggregation itself triggers aberrant interactions.
Davranche A; Aviolat H; Zeder-Lutz G; Busso D; Altschuh D; Trottier Y; Klein FA
Hum Mol Genet; 2011 Jul; 20(14):2795-806. PubMed ID: 21518730
[TBL] [Abstract][Full Text] [Related]
27. Enhanced Store-Operated Calcium Entry Leads to Striatal Synaptic Loss in a Huntington's Disease Mouse Model.
Wu J; Ryskamp DA; Liang X; Egorova P; Zakharova O; Hung G; Bezprozvanny I
J Neurosci; 2016 Jan; 36(1):125-41. PubMed ID: 26740655
[TBL] [Abstract][Full Text] [Related]
28. Small, Seeding-Competent Huntingtin Fibrils Are Prominent Aggregate Species in Brains of zQ175 Huntington's Disease Knock-in Mice.
Schindler F; Praedel N; Neuendorf N; Kunz S; Schnoegl S; Mason MA; Taxy BA; Bates GP; Khoshnan A; Priller J; Grimm J; Maier M; Boeddrich A; Wanker EE
Front Neurosci; 2021; 15():682172. PubMed ID: 34239412
[TBL] [Abstract][Full Text] [Related]
29. Effects of Exogenous NUB1 Expression in the Striatum of HDQ175/Q7 Mice.
Vodicka P; Chase K; Iuliano M; Valentine DT; Sapp E; Lu B; Kegel-Gleason KB; Sena-Esteves M; Aronin N; DiFiglia M
J Huntingtons Dis; 2016 Jun; 5(2):163-74. PubMed ID: 27314618
[TBL] [Abstract][Full Text] [Related]
30. Gedunin Degrades Aggregates of Mutant Huntingtin Protein and Intranuclear Inclusions via the Proteasomal Pathway in Neurons and Fibroblasts from Patients with Huntington's Disease.
Yang W; Xie J; Qiang Q; Li L; Lin X; Ren Y; Ren W; Liu Q; Zhou G; Wei W; Saiyin H; Ma L
Neurosci Bull; 2019 Dec; 35(6):1024-1034. PubMed ID: 31432317
[TBL] [Abstract][Full Text] [Related]
31. Mutant huntingtin protein induces MLH1 degradation, DNA hyperexcision, and cGAS-STING-dependent apoptosis.
Sun X; Liu L; Wu C; Li X; Guo J; Zhang J; Guan J; Wang N; Gu L; Yang XW; Li GM
Proc Natl Acad Sci U S A; 2024 Mar; 121(13):e2313652121. PubMed ID: 38498709
[TBL] [Abstract][Full Text] [Related]
32. Promoters are differentially sensitive to N-terminal mutant huntingtin-mediated transcriptional repression.
Hogel M; Laprairie RB; Denovan-Wright EM
PLoS One; 2012; 7(7):e41152. PubMed ID: 22815947
[TBL] [Abstract][Full Text] [Related]
33. HSF1 and Its Role in Huntington's Disease Pathology.
Kim H; Gomez-Pastor R
Adv Exp Med Biol; 2023; 1410():35-95. PubMed ID: 36396925
[TBL] [Abstract][Full Text] [Related]
34. Comparison of mHTT Antibodies in Huntington's Disease Mouse Models Reveal Specific Binding Profiles and Steady-State Ubiquitin Levels with Disease Development.
Bayram-Weston Z; Jones L; Dunnett SB; Brooks SP
PLoS One; 2016; 11(5):e0155834. PubMed ID: 27196694
[TBL] [Abstract][Full Text] [Related]
35. PIN1 Modulates Huntingtin Levels and Aggregate Accumulation: An
Carnemolla A; Michelazzi S; Agostoni E
Front Cell Neurosci; 2017; 11():121. PubMed ID: 28533744
[TBL] [Abstract][Full Text] [Related]
36. Subcellular Clearance and Accumulation of Huntington Disease Protein: A Mini-Review.
Zhao T; Hong Y; Li XJ; Li SH
Front Mol Neurosci; 2016; 9():27. PubMed ID: 27147961
[TBL] [Abstract][Full Text] [Related]
37. Palmitoylation and trafficking of GAD65 are impaired in a cellular model of Huntington's disease.
Rush DB; Leon RT; McCollum MH; Treu RW; Wei J
Biochem J; 2012 Feb; 442(1):39-48. PubMed ID: 22103299
[TBL] [Abstract][Full Text] [Related]
38. Ubiquitin-activating enzyme activity contributes to differential accumulation of mutant huntingtin in brain and peripheral tissues.
Wade BE; Wang CE; Yan S; Bhat K; Huang B; Li S; Li XJ
J Neurosci; 2014 Jun; 34(25):8411-22. PubMed ID: 24948797
[TBL] [Abstract][Full Text] [Related]
39. Altered Expression of Matrix Metalloproteinases and Their Endogenous Inhibitors in a Human Isogenic Stem Cell Model of Huntington's Disease.
Naphade S; Embusch A; Madushani KL; Ring KL; Ellerby LM
Front Neurosci; 2017; 11():736. PubMed ID: 29459817
[TBL] [Abstract][Full Text] [Related]
40. Formation and toxicity of soluble polyglutamine oligomers in living cells.
Lajoie P; Snapp EL
PLoS One; 2010 Dec; 5(12):e15245. PubMed ID: 21209946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
